Keyphrases
Cost-effectiveness
100%
Family History
100%
Genetic Polymorphism
100%
Prostate Cancer
100%
Chemoprevention
100%
Finasteride
100%
Quality-adjusted Life Years
44%
Risk Allele
33%
High-risk Population
22%
Genetic Testing
22%
High Risk
11%
Positive Family History
11%
Patient Identification
11%
Medical Literature
11%
50 Years Old
11%
Markov Model
11%
Model Use
11%
Online Sources
11%
Incremental Cost-effectiveness Ratio
11%
National Cancer Registry
11%
Total Expenditure
11%
Prostate Cancer Chemoprevention
11%
Medicine and Dentistry
Cost-Effectiveness Analysis
100%
Genetic Polymorphism
100%
Prostate Cancer
100%
Family History
100%
Chemoprophylaxis
100%
Pilus
100%
High Risk Population
50%
Quality Adjusted Life Year
50%
Allele
37%
Health Care Cost
25%
Genetic Screening
25%
Chemoprevention
12%
Cancer Registry
12%
Chemoprevention Strategy
12%
Nursing and Health Professions
Chemoprophylaxis
100%
Family History
100%
Cost Effectiveness Analysis
100%
Prostate Cancer
100%
High Risk Population
40%
Quality Adjusted Life Year
40%
Genetic Screening
20%
Cancer Registry
10%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Finasteride
100%
Cancer Registry
20%